Con­grat­u­la­tions to Peter Hege­mann and Georg Nagel on win­ning the Nobel Prize in Physiology or Medicine

Georg Nagel and Peter Hegemann, from the left (photo edited using AI)
Georg Nagel and Peter Hege­mann, from the left (photo edited using AI)

Con­grat­u­la­tions to Peter Hege­mann and Georg Nagel on win­ning the Nobel Prize in Physiology or Medicine

Martin Lohse, CEO of ISAR Bioscience, con­grat­u­lates his long-stand­ing col­lab­or­a­tion partners.

For the inven­tion of opto­gen­et­ics, Georg Nagel of the Uni­ver­sity of Würzburg and Peter Hege­mann of the Hum­boldt Uni­ver­sity Ber­lin will receive the 2026 Nobel Prize in Physiology or Medi­cine. They will be honored together with Karl Deis­seroth of Stan­ford University.

In the 1990s, Peter Hege­mann dis­covered pro­teins that enable green algae to respond to light. Georg Nagel suc­ceeded in demon­strat­ing that these pro­teins are ion chan­nels that can be activ­ated by blue light. Nagel and Hege­mann named these pro­teins chan­nelrhodopsins. In terms of their struc­ture and light sens­it­iv­ity, they resemble the human eye’s visual receptor, rhodop­sin. Unlike rhodop­sin, how­ever, chan­nelrhodopsins can con­duct ions. Karl Deis­seroth ulti­mately suc­ceeded in intro­du­cing these pro­teins into indi­vidual nerve cells and manip­u­lat­ing them spe­cific­ally with light. This laid the found­a­tion for opto­gen­et­ics: the sci­ence of influ­en­cing nerve cells — and thus per­cep­tions and beha­vior — through light.

Georg Nagel researched the prop­er­ties of chan­nelrhodopsins at the Uni­ver­sity of Würzburg, includ­ing in the Col­lab­or­at­ive Research Cen­ter “Reg­u­lat­ory Mem­brane Pro­teins” foun­ded by Martin Lohse, and in the Trans­re­g­ional Col­lab­or­at­ive Research Cen­ter “Receptor Light” at the Uni­ver­sit­ies of Jena and Würzburg. As is often the case with ground­break­ing research, fund­ing for “Receptor Light” was dis­con­tin­ued earlier than hoped — just a few years before the Nobel Prize.

Peter Hege­mann con­duc­ted research along­side Martin Lohse at the Max Planck Insti­tute for Bio­chem­istry in Mar­tin­sried in the 1990s. At that time, their work focused on rhodopsins in bac­teria. In 2017 and 2018, the two jointly developed the concept for an ima­ging cen­ter in Ber­lin. Under the name “Ima­ging Innov­a­tion Cen­ter,” it is sched­uled to open in the spring of 2027 at the MDC in Berlin-Buch.

Con­grat­u­la­tions to both laureates!

back BACK